AUSTIN, Texas and CANOGA PARK, Calif, Nov. 10 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) and One Lambda, Inc. announced today that they have entered into a multi-year strategic partnership to develop Human Leukocyte Antigen (HLA)-based applications on the Luminex LabMAP(TM) technology.
AUSTIN, Texas, Oct. 25 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX - news ) today announced its financial results for the quarter and nine months ended September 30, 2000. Revenues for the third quarter increased by more than 400% to $2.3 million, compared with the same period of 1999, and
AUSTIN, Texas, Oct. 16 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) will announce financial results for the third quarter after the market closes on October 25, 2000. Management of the company will hold a conference call on Thursday, October 26th at 10:00 a.m.
AUSTIN, Texas, and LAKE PLACID, N.Y., Oct. 5 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) and Upstate Biotechnology announced today that they have entered into a strategic partnership to develop reagents and assay kits for basic research and drug discovery applications based on Luminex's
AUSTIN, Texas, Oct. 2 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today unveiled details of a major project that will enable the detection and treatment of diseases at earlier stages by elucidating certain biochemical changes detectable only in blood.
Contacts: Luminex Corporation (512) 219-8020 Ralph L. McDade, Ph.D. Vice-President , Scientific Affairs Noonan/Russo Communications (212) 696-4455 Joy Bessenger (Investors) Tony Ho Loke (Media) - Luminex To Partner with Life Technologies on NIST ATP Program - AUSTIN, TX., September 13, 2000 -
ROCKVILLE, Md., Sept. 12 /PRNewswire/ -- Life Technologies, Inc. (OTC Bulletin Board: LTEK.OB) today announced participation in a three-year, multi-million dollar Advanced Technology Program (ATP) from The National Institute of Standards and Technology (NIST), of Gaithersburg, Maryland to support